Bank of New York Mellon Corp - KURA ONCOLOGY INC ownership

KURA ONCOLOGY INC's ticker is KURA and the CUSIP is 50127T109. A total of 156 filers reported holding KURA ONCOLOGY INC in Q3 2021. The put-call ratio across all filers is 0.46 and the average weighting 0.2%.

Quarter-by-quarter ownership
Bank of New York Mellon Corp ownership history of KURA ONCOLOGY INC
ValueSharesWeighting
Q3 2023$2,387,105
-4.4%
261,744
+10.9%
0.00%0.0%
Q2 2023$2,497,589
-9.5%
236,067
+4.7%
0.00%0.0%
Q1 2023$2,758,488
-3.6%
225,551
-2.2%
0.00%0.0%
Q4 2022$2,862,552
-8.4%
230,665
+0.9%
0.00%0.0%
Q3 2022$3,124,000
-17.6%
228,661
+10.5%
0.00%0.0%
Q2 2022$3,791,000
+1.8%
206,840
-10.7%
0.00%0.0%
Q1 2022$3,724,000
+15.2%
231,653
+0.4%
0.00%0.0%
Q4 2021$3,232,000
-32.4%
230,841
-9.5%
0.00%0.0%
Q3 2021$4,778,000
+4.8%
255,071
+16.6%
0.00%0.0%
Q2 2021$4,561,000
-45.9%
218,720
-26.7%
0.00%
-50.0%
Q1 2021$8,434,000
-9.6%
298,342
+4.5%
0.00%0.0%
Q4 2020$9,328,000
+25.5%
285,596
+17.7%
0.00%0.0%
Q3 2020$7,432,000
+120.4%
242,589
+17.3%
0.00%
+100.0%
Q2 2020$3,372,000
+126.2%
206,893
+38.1%
0.00%
Q1 2020$1,491,000
-25.2%
149,828
+3.4%
0.00%
-100.0%
Q4 2019$1,993,000
-6.9%
144,909
+2.7%
0.00%0.0%
Q3 2019$2,140,000
-10.6%
141,088
+16.0%
0.00%0.0%
Q2 2019$2,395,000
+18.3%
121,652
-0.3%
0.00%0.0%
Q1 2019$2,025,000
+18.7%
122,066
+0.5%
0.00%0.0%
Q4 2018$1,706,000
-13.2%
121,473
+8.2%
0.00%0.0%
Q3 2018$1,965,000
+5.5%
112,255
+9.7%
0.00%0.0%
Q2 2018$1,863,000
+19.3%
102,371
+22.9%
0.00%
Q1 2018$1,562,000
+52.5%
83,299
+24.4%
0.00%
Q4 2017$1,024,000
+15.6%
66,936
+12.9%
0.00%
Q3 2017$886,000
+204.5%
59,281
+89.7%
0.00%
Q2 2017$291,00031,2500.00%
Other shareholders
KURA ONCOLOGY INC shareholders Q3 2021
NameSharesValueWeighting ↓
Foresite Capital Management IV, LLC 1,849,947$16,871,5179.37%
Prosight Management, LP 1,932,456$17,623,9995.58%
ACUTA CAPITAL PARTNERS, LLC 702,093$6,403,0884.29%
ALETHEA CAPITAL MANAGEMENT, LLC 350,445$3,196,0583.93%
SUVRETTA CAPITAL MANAGEMENT, LLC 7,335,845$66,902,9063.62%
Affinity Asset Advisors, LLC 856,535$7,811,5992.20%
TCG Crossover Management, LLC 1,423,642$12,983,6151.91%
EcoR1 Capital, LLC 5,806,871$52,958,6641.79%
BVF INC/IL 6,730,983$61,386,5651.66%
DAFNA Capital Management LLC 550,784$5,023,1501.56%
View complete list of KURA ONCOLOGY INC shareholders